Hanno Santelmann1, Jeremy Franklin2, Jana Bußhoff1, Christopher Baethge1. 1. Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, NRW, Germany. 2. Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne Medical School, Cologne, NRW, Germany.
Abstract
OBJECTIVES: Schizoaffective disorder is a frequent diagnosis, and its reliability is subject to ongoing discussion. We compared the diagnostic reliability of schizoaffective disorder with its main differential diagnoses. METHODS: We systematically searched Medline, Embase, and PsycInfo for all studies on the test-retest reliability of the diagnosis of schizoaffective disorder as compared with schizophrenia, bipolar disorder, and unipolar depression. We used meta-analytic methods to describe and compare Cohen's kappa as well as positive and negative agreement. In addition, multiple pre-specified and post hoc subgroup and sensitivity analyses were carried out. RESULTS: Out of 4,415 studies screened, 49 studies were included. Test-retest reliability of schizoaffective disorder was consistently lower than that of schizophrenia (in 39 out of 42 studies), bipolar disorder (27/33), and unipolar depression (29/35). The mean difference in kappa between schizoaffective disorder and the other diagnoses was approximately 0.2, and mean Cohen's kappa for schizoaffective disorder was 0.50 (95% confidence interval: 0.40-0.59). While findings were unequivocal and homogeneous for schizoaffective disorder's diagnostic reliability relative to its three main differential diagnoses (dichotomous: smaller versus larger), heterogeneity was substantial for continuous measures, even after subgroup and sensitivity analyses. CONCLUSIONS: In clinical practice and research, schizoaffective disorder's comparatively low diagnostic reliability should lead to increased efforts to correctly diagnose the disorder.
OBJECTIVES: Schizoaffective disorder is a frequent diagnosis, and its reliability is subject to ongoing discussion. We compared the diagnostic reliability of schizoaffective disorder with its main differential diagnoses. METHODS: We systematically searched Medline, Embase, and PsycInfo for all studies on the test-retest reliability of the diagnosis of schizoaffective disorder as compared with schizophrenia, bipolar disorder, and unipolar depression. We used meta-analytic methods to describe and compare Cohen's kappa as well as positive and negative agreement. In addition, multiple pre-specified and post hoc subgroup and sensitivity analyses were carried out. RESULTS: Out of 4,415 studies screened, 49 studies were included. Test-retest reliability of schizoaffective disorder was consistently lower than that of schizophrenia (in 39 out of 42 studies), bipolar disorder (27/33), and unipolar depression (29/35). The mean difference in kappa between schizoaffective disorder and the other diagnoses was approximately 0.2, and mean Cohen's kappa for schizoaffective disorder was 0.50 (95% confidence interval: 0.40-0.59). While findings were unequivocal and homogeneous for schizoaffective disorder's diagnostic reliability relative to its three main differential diagnoses (dichotomous: smaller versus larger), heterogeneity was substantial for continuous measures, even after subgroup and sensitivity analyses. CONCLUSIONS: In clinical practice and research, schizoaffective disorder's comparatively low diagnostic reliability should lead to increased efforts to correctly diagnose the disorder.
Authors: Geoffrey M Reed; Pratap Sharan; Tahilia J Rebello; Jared W Keeley; María Elena Medina-Mora; Oye Gureje; José Luis Ayuso-Mateos; Shigenobu Kanba; Brigitte Khoury; Cary S Kogan; Valery N Krasnov; Mario Maj; Jair de Jesus Mari; Dan J Stein; Min Zhao; Tsuyoshi Akiyama; Howard F Andrews; Elson Asevedo; Majda Cheour; Tecelli Domínguez-Martínez; Joseph El-Khoury; Andrea Fiorillo; Jean Grenier; Nitin Gupta; Lola Kola; Maya Kulygina; Itziar Leal-Leturia; Mario Luciano; Bulumko Lusu; J Nicolas; I Martínez-López; Chihiro Matsumoto; Lucky Umukoro Onofa; Sabrina Paterniti; Shivani Purnima; Rebeca Robles; Manoj K Sahu; Goodman Sibeko; Na Zhong; Michael B First; Wolfgang Gaebel; Anne M Lovell; Toshimasa Maruta; Michael C Roberts; Kathleen M Pike Journal: World Psychiatry Date: 2018-06 Impact factor: 49.548
Authors: Michael B First; Wolfgang Gaebel; Mario Maj; Dan J Stein; Cary S Kogan; John B Saunders; Vladimir B Poznyak; Oye Gureje; Roberto Lewis-Fernández; Andreas Maercker; Chris R Brewin; Marylene Cloitre; Angelica Claudino; Kathleen M Pike; Gillian Baird; David Skuse; Richard B Krueger; Peer Briken; Jeffrey D Burke; John E Lochman; Spencer C Evans; Douglas W Woods; Geoffrey M Reed Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548
Authors: Matthias Guggenmos; Katharina Schmack; Ilya M Veer; Tristram Lett; Maria Sekutowicz; Miriam Sebold; Maria Garbusow; Christian Sommer; Hans-Ulrich Wittchen; Ulrich S Zimmermann; Michael N Smolka; Henrik Walter; Andreas Heinz; Philipp Sterzer Journal: Sci Rep Date: 2020-01-15 Impact factor: 4.379